PLTR Palantir Technologies Inc. Insider Trading

Director Alexander D. Moore sells 16,000 shares of PLTR for $2,144,770.09 via 10b5-1 plan

Alexander D. Moore executed 4 separate sales totaling 16,000 shares for $2,144,770.09 on 2026-07-15 at prices ranging from $133.75 to $136.79, reducing his holdings from 1,111,095 shares to 1,095,095 shares. This transaction is part of a pre-arranged 10b5-1 trading plan and therefore scheduled rather than discretionary. Moore's cross-ticker track record shows 20 prior sells with an average 90-day return of -7.3%, while his five prior sales at PLTR on 2026-06-15 produced mixed near-term returns ranging from -0.5% to +2.5% over 30 days. PLTR trades at -36.2% from its 52-week high of $207.52 and carries a P/E of 139.35 against recent quarterly revenue of $1,632,583,000.00 and net income of $870,527,000.00.

Shyam Sankar sold 185,000 shares at $130.00 for $24,050,000.00 via scheduled 10b5-1 plan

Shyam Sankar executed 2 separate sales totaling 185,000 shares for $24,050,000.00 at $130.00 per share on 2026-07-02, reducing non-derivative holdings from 784,899 to 599,899 shares (-23.6%). This transaction is part of a pre-arranged 10b5-1 trading plan and therefore scheduled, not discretionary. The sales occurred when PLTR stock was trading at $134.37, approximately -35.2% from its 52-week high of $207.52. Sankar retains 3,663,598 derivative shares (Class B Common Stock), so his overall economic position remains substantial despite the non-derivative sale. His prior trades at PLTR show consistent negative 30-day returns (ranging -6.0% to -3.4%), though his broader cross-ticker track record shows mixed timing with an average 90-day return of -8.7% after prior sells.

Director Alexander D. Moore sells 16,000 PLTR shares for $2.1M via 5 scheduled transactions; retains 1.11M shares post-sale

Alexander D. Moore, a Director at Palantir Technologies, executed 5 separate sales totaling 16,000 shares for $2,133,605.15 on 2026-06-15, reducing his holdings from 1,127,095 to 1,111,095 shares (a -1.4% reduction). The transaction was executed under a pre-arranged 10b5-1 trading plan, meaning the timing and quantity were scheduled in advance rather than discretionary. The blended average sale price of $133.35 sits above the current price of $130.63, though the stock remains significantly below its 52-week high of $207.52 (currently -37.0% from peak). Moore's prior trades at PLTR over the last two months (5 sells between 2026-04-15 and 2026-05-15) experienced negative 30-day and near-term returns ranging from -3.8% to -5.9%, consistent with his cross-ticker track record average 90-day return of -8.2%. The scheduled nature of this filing, combined with the stock's ongoing weakness and Moore's established pattern of post-sale declines at this ticker, provides limited forward-looking signal; investors should note the substantial remaining holdings (1.11M shares) indicate material continuing exposure.

Moore Alexander D. (Director) sold 16,000 shares at avg $134.04 on 2026-05-15 under 10b5-1 plan; retains 1,124,978 shares.

Moore Alexander D. sold 16,000 shares across four separate transactions for $2,144,662.94 at an average price of $134.04 on 2026-05-15, reducing his holdings from 1,140,978 shares to 1,124,978 shares. This sale was executed under a pre-arranged 10b5-1 trading plan, meaning it was scheduled rather than discretionary. His cross-ticker track record shows 20 prior sells with average 90-day returns of -6.6%, while his five prior sales at PLTR showed negative 90-day outcomes ranging from -1.1% to -5.1%. The stock's 52-week high was $207.52 and current price is $135.26 at -34.8% from peak, with a 30-day decline of -7.6%.

Director Moore Alexander D. sold 16,000 shares of PLTR for $2,230,580.45 via scheduled 10b5-1 plan on 2026-04-15

Director Moore Alexander D. executed 8 separate sales totaling 16,000 shares for $2,230,580.45 on 2026-04-15 across a range of prices from $135.70 to $142.41, with a blended average price of $139.41. This transaction was part of a pre-arranged 10b5-1 trading plan, meaning it was scheduled rather than discretionary. Post-transaction holdings remain substantial at 1,140,978 shares, representing a -1.4% reduction from pre-transaction holdings of 1,156,978 shares. The multiple-tranche execution structure across different price points reflects the mechanics of a structured trading program rather than a single concentrated decision.

Director Moore sells 16,000 PLTR shares for $2.4M at blended avg $152.41 on 2026-03-16

Moore Alexander D., a Director of Palantir, executed 3 separate sales totaling 16,000 shares for $2,438,622.65 on 2026-03-16, reducing his holdings from 1,172,978 shares to 1,156,978 shares (-1.4%). The sales were executed at prices ranging from $151.99 to $153.51, with a blended average of $152.41, near the current price of $152.77. Cross-ticker analysis shows Moore has a historical well-timed rate of 100.00% on his 20 prior sells (all instances of selling followed by stock declines), though at PLTR specifically his 5 prior sales on 2026-02-02 produced modest positive 30-day returns (1.5% to 3.9%) with no measurable 90-day outcomes yet. The current transaction represents a modest liquidation relative to his substantial post-sale holdings of 1.16M shares, occurring as PLTR is trading 26.3% below its 52-week high despite strong fundamentals (Revenue $1,181,092,000, Net income $475,599,000, +56.2% annual growth).

Peter Thiel sold 2,000,000 shares for $289.7M via 7 transactions (blended avg $144.85) under 10b5-1 plan adopted 2025-11-14.

Peter Thiel, a Palantir director, executed 7 separate sales totaling 2,000,000 shares for $289,707,507.04 on 2026-03-02 under a pre-arranged 10b5-1 trading plan adopted on 2025-11-14. This sale reduces his holdings from 15,733,625 shares to 13,733,625 shares, a -12.7% reduction. The transaction is scheduled and discretionary-free under the 10b5-1 framework, meaning the timing and pricing reflect plan mechanics rather than active judgment on current valuation or company trajectory. The magnitude—$289.7M across seven tranches at prices ranging from $140.97 to $146.80—represents a substantial reduction in his stake, though his post-transaction holdings remain material at 13.73M shares.

Palantir insider Karp Alexander C. sold 90,000 shares for $12.1M under 10b5-1 plan on 2026-02-20

Karp Alexander C. executed 5 separate sales totaling 90,000 shares for $12,064,116.89 at prices ranging from $132.01 to $135.67, reducing his holdings from 6,522,258 shares to 6,432,258 shares (a 1.4% reduction). This transaction was conducted under a pre-arranged 10b5-1 trading plan, making it a scheduled, non-discretionary sale rather than a discretionary choice. The filing includes a derivative-conversion element that means his Table I common-share position does not reflect his total holdings. The blended average sale price of $134.05 across the five tranches represents execution at incremental price points on the filing date, characteristic of algorithmic or scheduled-plan execution rather than a concentrated tactical decision.

Director Moore Alexander D. sold 20,000 shares of PLTR for $2,992,983.81 via 10b5-1 plan on 2026-02-02.

Director Moore Alexander D. executed five separate sales totaling 20,000 shares for $2,992,983.81 on 2026-02-02, reducing his holdings from 1,192,978 shares to 1,172,978 shares—a -1.7% reduction. The transaction was conducted under a pre-arranged 10b5-1 trading plan, meaning it was scheduled and not discretionary. The blended average price across the five sales was $149.65. With 1.17M shares retained post-transaction, the director maintains a substantial ongoing stake in PLTR. As this sale was pre-planned under Rule 10b5-1, it reflects a predetermined execution schedule rather than a response to current market conditions or company circumstances.

Director Moore sells 20,000 shares across 13 transactions for $3.5M on 2026-01-02; maintains 1.19M shares post-transaction.

Moore Alexander D. executed 13 separate sales totaling 20,000 shares for $3,459,614.81 at prices ranging from $167.30 to $181.04, with a blended average of $172.98. The current stock price of $179.71 is 13.3% below the 52-week high of $207.18, suggesting the stock has retreated materially from its peak. His holdings remain substantial at 1.19M shares, down only 1.6% from pre-transaction levels, indicating this was a targeted partial liquidation rather than a major portfolio shift. At PLTR specifically, Moore has completed five sales over the preceding month (all dated 2025-12-01), each showing positive 30-day returns (ranging from +5.6% to +8.3%), signaling that his prior near-term sales at this ticker have preceded rally continuation; the 90-day outcome for those trades is not yet measurable.